The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Ultra-high purity surfactant for biologics and parenteral drug formulations
Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
Cagrilintide represents a novel approach to obesity management
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
Vonvendi is the only recombinant Von Willebrand factor replacement therapy with approved indications in adults and children with VWD
Subscribe To Our Newsletter & Stay Updated
